Portable Breast MRI
7 Costly FDA Mistakes EU Medical Device Companies Make
November 11, 2025
Long-Term Melatonin Use: What Toxicology, Regulation & Product Development Must Learn Now
November 11, 2025
By Harriet Kamendi, PhD | November 14, 2025 | Medical Innovation, Women’s Health
For millions of women around the world, a “clear” mammogram result can be a dangerous false reassurance. The hard truth is that mammograms miss up to 40% of breast cancers in women with dense breast tissue. This isn’t a rare issue—it’s a global clinical blind spot that turns early, treatable cancer into a late-stage crisis.
Today, we’re unveiling a paradigm shift: the Kandih Portable Breast MRI. We’re not just improving existing technology; we’re reimagining it from the ground up to make gold-standard screening accessible to all women, everywhere.
The Unseen Epidemic: Why “Standard” Screening is Failing Women
The problem is two-fold: clinical failure and infrastructural failure.
The Clinical Failure:
- Dense Tissue Hides Cancer: On a mammogram, both dense breast tissue and tumors appear white. It’s like trying to find a snowball in a snowstorm.
- Radiation Limits Frequency: The ionizing radiation in mammograms limits how often women, especially younger ones, can be safely screened.
- Contrast Agents Carry Risks: Traditional MRIs require injected contrast agents, which some patients cannot tolerate.
The Infrastructural Failure:
- Cost Prohibits Access: A traditional MRI machine costs over $1 million.
- Immovable Infrastructure: These machines require specialized rooms, massive power grids, and complex maintenance.
- Expert-Dependent: They need highly trained radiologists on-site or nearby.
The result? A catastrophic delay in diagnosis. Late-stage treatment costs can be 300 times higher than early-stage intervention, and survival rates plummet from over 90% to below 40% in underserved regions.
A New Hope: The Three Breakthroughs Making Portable MRI Possible
We’ve tackled this problem with a physics-first approach, leading to three core innovations:
1. The Quantum Trick: Seeing Cancer’s Natural Glow
We discovered that cancer proteins have a unique quantum signature at a low magnetic field. By tuning our device to this “secret radio station,” we can see cancer light up without any injected contrast agents. This makes the procedure safer and simpler.
2. The Camera Flash Magnets: Replacing the Giant Magnet
We replaced the huge, always-on superconducting magnet—the core of every traditional MRI—with an array of smart magnets. These pulse on for microseconds, like a camera flash. This breakthrough slashes power consumption, eliminates cryogenic cooling, and reduces the size and weight of the unit dramatically.
3. The Wiggle & Subtract: Islecting the Signal from the Noise
We take two quick images: one just above and one just below the 66.7 mT field. By subtracting them, we digitally cancel out all the normal, healthy tissue. What remains is a clear, black-background image where only the cancer cells are highlighted.
Together, these innovations deliver a 10-second scan with >90% sensitivity, in a device that plugs into a standard wall outlet.
Why This Isn’t Just an Incremental Improvement
The Kandih Portable Breast MRI is the only solution that works for patients, providers, and payers simultaneously.
| For Patients | For Clinics & Hospitals | For Healthcare Systems |
| >90% sensitivity, even in dense tissue | Low Capex: $120K-$200K (vs. $1M+) | Dramatically lower cost per scan: <$25 |
| No painful compression | Plugs into a standard outlet | Scalable to rural & remote areas |
| No radiation; safe for frequent screening | AI-powered for easy operation | Earlier detection reduces late-stage treatment costs |
| Quick, 5-minute procedure | Remote radiologist reading capability | Aligns with WHO’s global breast cancer initiative |
The Team Behind the Technology
This breakthrough is built on a foundation of proven expertise:
- Dr. Irving Weinberg, MD, PhD: A pioneering medical physicist and serial entrepreneur with multiple successful FDA-approved device exits, including Promaxo.
- Daniel Ndiki, MS EE: An engineer with experience in mission-critical systems from NASA and the University of Maryland.
- Harriet Kamendi, PhD, DABT: A regulatory strategist and toxicologist with deep expertise in guiding medical devices through FDA and global approvals.
Our technology is backed by over 20 issued patents held by Weinberg Medical Physics.
The Future is Accessible
Our vision is to screen 5 million women by 2030, starting with the most acute needs in Africa and expanding to rural and underserved communities worldwide. This isn’t just a new device; it’s a new infrastructure for global health equity.
Join Us in This Mission
We are at a pivotal moment. We are actively seeking:
- Strategic Investors for our Series A round.
- Development & Manufacturing Partners to scale production.
- Commercialization & Distribution Partners to bring this technology to every corner of the globe.
Ready to see the future of breast cancer screening?
Let’s connect and discuss how we can partner to save millions of lives.
Contact us today to request the full technical brief or to schedule a meeting.
Harriet Kamendi, PhD
CEO & Founder, Kandih BioScience
CEO & Founder BioImaging Inc
hkamendi@kandih.com
Kandih.com
